
The hemoperfusion machine is a dialysis instrument and equipment that draws the patient's blood out of the body and removes the exogenous and endogenous toxins in the blood through the adsorption of the perfusion device.
The global market for Hemoperfusion Machines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion Machines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemoperfusion Machines by region & country, by Type, and by Application.
The Hemoperfusion Machines market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Machines.
Market Segmentation
By Company
Baxter (Gambro)
Toray Industries
HAMNEST CARE
Asahi-Kasei
Delvin
Kaneka
Cytosorbents
Jafron Biomedical
Guangdong Biolight Meditech
Shenzhen Landwind Industry
SWS Medical Group
Foshan Biosun Medical Technology
Zhangjiagang Combilong Machinery
Segment by Type:
Single Pump Hemoperfusion Machines
Dual-pump Hemoperfusion Machines
Segment by Application
Uremia
Poisoning
Severe Liver Disease
Hyperbilirubinemia
Systemic Lupus Erythematosus
Allergic Purpura and Rheumatoid Arthritis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemoperfusion Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemoperfusion Machines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemoperfusion Machines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Hemoperfusion Machines Product Introduction
1.2 Global Hemoperfusion Machines Market Size Forecast
1.2.1 Global Hemoperfusion Machines Sales Value (2019-2030)
1.2.2 Global Hemoperfusion Machines Sales Volume (2019-2030)
1.2.3 Global Hemoperfusion Machines Sales Price (2019-2030)
1.3 Hemoperfusion Machines Market Trends & Drivers
1.3.1 Hemoperfusion Machines Industry Trends
1.3.2 Hemoperfusion Machines Market Drivers & Opportunity
1.3.3 Hemoperfusion Machines Market Challenges
1.3.4 Hemoperfusion Machines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemoperfusion Machines Players Revenue Ranking (2023)
2.2 Global Hemoperfusion Machines Revenue by Company (2019-2024)
2.3 Global Hemoperfusion Machines Players Sales Volume Ranking (2023)
2.4 Global Hemoperfusion Machines Sales Volume by Company Players (2019-2024)
2.5 Global Hemoperfusion Machines Average Price by Company (2019-2024)
2.6 Key Manufacturers Hemoperfusion Machines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hemoperfusion Machines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemoperfusion Machines
2.9 Hemoperfusion Machines Market Competitive Analysis
2.9.1 Hemoperfusion Machines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemoperfusion Machines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion Machines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Pump Hemoperfusion Machines
3.1.2 Dual-pump Hemoperfusion Machines
3.2 Global Hemoperfusion Machines Sales Value by Type
3.2.1 Global Hemoperfusion Machines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hemoperfusion Machines Sales Value, by Type (2019-2030)
3.2.3 Global Hemoperfusion Machines Sales Value, by Type (%) (2019-2030)
3.3 Global Hemoperfusion Machines Sales Volume by Type
3.3.1 Global Hemoperfusion Machines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hemoperfusion Machines Sales Volume, by Type (2019-2030)
3.3.3 Global Hemoperfusion Machines Sales Volume, by Type (%) (2019-2030)
3.4 Global Hemoperfusion Machines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Uremia
4.1.2 Poisoning
4.1.3 Severe Liver Disease
4.1.4 Hyperbilirubinemia
4.1.5 Systemic Lupus Erythematosus
4.1.6 Allergic Purpura and Rheumatoid Arthritis
4.1.7 Others
4.2 Global Hemoperfusion Machines Sales Value by Application
4.2.1 Global Hemoperfusion Machines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hemoperfusion Machines Sales Value, by Application (2019-2030)
4.2.3 Global Hemoperfusion Machines Sales Value, by Application (%) (2019-2030)
4.3 Global Hemoperfusion Machines Sales Volume by Application
4.3.1 Global Hemoperfusion Machines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hemoperfusion Machines Sales Volume, by Application (2019-2030)
4.3.3 Global Hemoperfusion Machines Sales Volume, by Application (%) (2019-2030)
4.4 Global Hemoperfusion Machines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hemoperfusion Machines Sales Value by Region
5.1.1 Global Hemoperfusion Machines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hemoperfusion Machines Sales Value by Region (2019-2024)
5.1.3 Global Hemoperfusion Machines Sales Value by Region (2025-2030)
5.1.4 Global Hemoperfusion Machines Sales Value by Region (%), (2019-2030)
5.2 Global Hemoperfusion Machines Sales Volume by Region
5.2.1 Global Hemoperfusion Machines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hemoperfusion Machines Sales Volume by Region (2019-2024)
5.2.3 Global Hemoperfusion Machines Sales Volume by Region (2025-2030)
5.2.4 Global Hemoperfusion Machines Sales Volume by Region (%), (2019-2030)
5.3 Global Hemoperfusion Machines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hemoperfusion Machines Sales Value, 2019-2030
5.4.2 North America Hemoperfusion Machines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hemoperfusion Machines Sales Value, 2019-2030
5.5.2 Europe Hemoperfusion Machines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hemoperfusion Machines Sales Value, 2019-2030
5.6.2 Asia Pacific Hemoperfusion Machines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hemoperfusion Machines Sales Value, 2019-2030
5.7.2 South America Hemoperfusion Machines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemoperfusion Machines Sales Value, 2019-2030
5.8.2 Middle East & Africa Hemoperfusion Machines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemoperfusion Machines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hemoperfusion Machines Sales Value
6.2.1 Key Countries/Regions Hemoperfusion Machines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hemoperfusion Machines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hemoperfusion Machines Sales Value, 2019-2030
6.3.2 United States Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hemoperfusion Machines Sales Value, 2019-2030
6.4.2 Europe Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hemoperfusion Machines Sales Value, 2019-2030
6.5.2 China Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hemoperfusion Machines Sales Value, 2019-2030
6.6.2 Japan Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hemoperfusion Machines Sales Value, 2019-2030
6.7.2 South Korea Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hemoperfusion Machines Sales Value, 2019-2030
6.8.2 Southeast Asia Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hemoperfusion Machines Sales Value, 2019-2030
6.9.2 India Hemoperfusion Machines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hemoperfusion Machines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Baxter (Gambro)
7.1.1 Baxter (Gambro) Company Information
7.1.2 Baxter (Gambro) Introduction and Business Overview
7.1.3 Baxter (Gambro) Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Baxter (Gambro) Hemoperfusion Machines Product Offerings
7.1.5 Baxter (Gambro) Recent Development
7.2 Toray Industries
7.2.1 Toray Industries Company Information
7.2.2 Toray Industries Introduction and Business Overview
7.2.3 Toray Industries Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Toray Industries Hemoperfusion Machines Product Offerings
7.2.5 Toray Industries Recent Development
7.3 HAMNEST CARE
7.3.1 HAMNEST CARE Company Information
7.3.2 HAMNEST CARE Introduction and Business Overview
7.3.3 HAMNEST CARE Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 HAMNEST CARE Hemoperfusion Machines Product Offerings
7.3.5 HAMNEST CARE Recent Development
7.4 Asahi-Kasei
7.4.1 Asahi-Kasei Company Information
7.4.2 Asahi-Kasei Introduction and Business Overview
7.4.3 Asahi-Kasei Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Asahi-Kasei Hemoperfusion Machines Product Offerings
7.4.5 Asahi-Kasei Recent Development
7.5 Delvin
7.5.1 Delvin Company Information
7.5.2 Delvin Introduction and Business Overview
7.5.3 Delvin Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Delvin Hemoperfusion Machines Product Offerings
7.5.5 Delvin Recent Development
7.6 Kaneka
7.6.1 Kaneka Company Information
7.6.2 Kaneka Introduction and Business Overview
7.6.3 Kaneka Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kaneka Hemoperfusion Machines Product Offerings
7.6.5 Kaneka Recent Development
7.7 Cytosorbents
7.7.1 Cytosorbents Company Information
7.7.2 Cytosorbents Introduction and Business Overview
7.7.3 Cytosorbents Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cytosorbents Hemoperfusion Machines Product Offerings
7.7.5 Cytosorbents Recent Development
7.8 Jafron Biomedical
7.8.1 Jafron Biomedical Company Information
7.8.2 Jafron Biomedical Introduction and Business Overview
7.8.3 Jafron Biomedical Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jafron Biomedical Hemoperfusion Machines Product Offerings
7.8.5 Jafron Biomedical Recent Development
7.9 Guangdong Biolight Meditech
7.9.1 Guangdong Biolight Meditech Company Information
7.9.2 Guangdong Biolight Meditech Introduction and Business Overview
7.9.3 Guangdong Biolight Meditech Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Guangdong Biolight Meditech Hemoperfusion Machines Product Offerings
7.9.5 Guangdong Biolight Meditech Recent Development
7.10 Shenzhen Landwind Industry
7.10.1 Shenzhen Landwind Industry Company Information
7.10.2 Shenzhen Landwind Industry Introduction and Business Overview
7.10.3 Shenzhen Landwind Industry Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shenzhen Landwind Industry Hemoperfusion Machines Product Offerings
7.10.5 Shenzhen Landwind Industry Recent Development
7.11 SWS Medical Group
7.11.1 SWS Medical Group Company Information
7.11.2 SWS Medical Group Introduction and Business Overview
7.11.3 SWS Medical Group Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SWS Medical Group Hemoperfusion Machines Product Offerings
7.11.5 SWS Medical Group Recent Development
7.12 Foshan Biosun Medical Technology
7.12.1 Foshan Biosun Medical Technology Company Information
7.12.2 Foshan Biosun Medical Technology Introduction and Business Overview
7.12.3 Foshan Biosun Medical Technology Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Foshan Biosun Medical Technology Hemoperfusion Machines Product Offerings
7.12.5 Foshan Biosun Medical Technology Recent Development
7.13 Zhangjiagang Combilong Machinery
7.13.1 Zhangjiagang Combilong Machinery Company Information
7.13.2 Zhangjiagang Combilong Machinery Introduction and Business Overview
7.13.3 Zhangjiagang Combilong Machinery Hemoperfusion Machines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Zhangjiagang Combilong Machinery Hemoperfusion Machines Product Offerings
7.13.5 Zhangjiagang Combilong Machinery Recent Development
8 Industry Chain Analysis
8.1 Hemoperfusion Machines Industrial Chain
8.2 Hemoperfusion Machines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemoperfusion Machines Sales Model
8.5.2 Sales Channel
8.5.3 Hemoperfusion Machines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Baxter (Gambro)
Toray Industries
HAMNEST CARE
Asahi-Kasei
Delvin
Kaneka
Cytosorbents
Jafron Biomedical
Guangdong Biolight Meditech
Shenzhen Landwind Industry
SWS Medical Group
Foshan Biosun Medical Technology
Zhangjiagang Combilong Machinery
Ìý
Ìý
*If Applicable.
